182 related articles for article (PubMed ID: 22333033)
1. L-asparaginase inhibits invasive and angiogenic activity and induces autophagy in ovarian cancer.
Yu M; Henning R; Walker A; Kim G; Perroy A; Alessandro R; Virador V; Kohn EC
J Cell Mol Med; 2012 Oct; 16(10):2369-78. PubMed ID: 22333033
[TBL] [Abstract][Full Text] [Related]
2. Cimetidine inhibits the adhesion of gastric cancer cells expressing high levels of sialyl Lewis x in human vascular endothelial cells by blocking E-selectin expression.
Liu FR; Jiang CG; Li YS; Li JB; Li F
Int J Mol Med; 2011 Apr; 27(4):537-44. PubMed ID: 21327325
[TBL] [Abstract][Full Text] [Related]
3. HECA-452 is a non-function blocking antibody for isolated sialyl Lewis x adhesion to endothelial expressed E-selectin under flow conditions.
Kummitha CM; Shirure VS; Delgadillo LF; Deosarkar SP; Tees DF; Burdick MM; Goetz DJ
J Immunol Methods; 2012 Oct; 384(1-2):43-50. PubMed ID: 22820001
[TBL] [Abstract][Full Text] [Related]
4. Andrographolide inhibits the adhesion of gastric cancer cells to endothelial cells by blocking E-selectin expression.
Jiang CG; Li JB; Liu FR; Wu T; Yu M; Xu HM
Anticancer Res; 2007; 27(4B):2439-47. PubMed ID: 17695536
[TBL] [Abstract][Full Text] [Related]
5. Identification of a metalloprotease-chemokine signaling system in the ovarian cancer microenvironment: implications for antiangiogenic therapy.
Agarwal A; Tressel SL; Kaimal R; Balla M; Lam FH; Covic L; Kuliopulos A
Cancer Res; 2010 Jul; 70(14):5880-90. PubMed ID: 20570895
[TBL] [Abstract][Full Text] [Related]
6. Alterations in human breast cancer adhesion-motility in response to changes in cell surface glycoproteins displaying alpha-L-fucose moieties.
Yuan K; Kucik D; Singh RK; Listinsky CM; Listinsky JJ; Siegal GP
Int J Oncol; 2008 Apr; 32(4):797-807. PubMed ID: 18360707
[TBL] [Abstract][Full Text] [Related]
7. Transgene expression of alpha(1,2)-fucosyltransferase-I (FUT1) in tumor cells selectively inhibits sialyl-Lewis x expression and binding to E-selectin without affecting synthesis of sialyl-Lewis a or binding to P-selectin.
Mathieu S; Prorok M; Benoliel AM; Uch R; Langlet C; Bongrand P; Gerolami R; El-Battari A
Am J Pathol; 2004 Feb; 164(2):371-83. PubMed ID: 14742243
[TBL] [Abstract][Full Text] [Related]
8. Action of fenretinide (4-HPR) on ovarian cancer and endothelial cells.
Golubkov V; Garcia A; Markland FS
Anticancer Res; 2005; 25(1A):249-53. PubMed ID: 15816545
[TBL] [Abstract][Full Text] [Related]
9. Thalidomide inhibits inflammatory and angiogenic activation of human intestinal microvascular endothelial cells (HIMEC).
Rafiee P; Stein DJ; Nelson VM; Otterson MF; Shaker R; Binion DG
Am J Physiol Gastrointest Liver Physiol; 2010 Feb; 298(2):G167-76. PubMed ID: 19926820
[TBL] [Abstract][Full Text] [Related]
10. L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways.
Gao F; Vasquez SX; Su F; Roberts S; Shah N; Grijalva V; Imaizumi S; Chattopadhyay A; Ganapathy E; Meriwether D; Johnston B; Anantharamaiah GM; Navab M; Fogelman AM; Reddy ST; Farias-Eisner R
Integr Biol (Camb); 2011 Apr; 3(4):479-89. PubMed ID: 21283904
[TBL] [Abstract][Full Text] [Related]
11. Cilostazol suppression of arterial intimal hyperplasia is associated with decreased expression of sialyl Lewis X homing receptors on mononuclear cells and E-selectin in endothelial cells.
Takigawa T; Tsurushima H; Suzuki K; Tsuruta W; Nakamura K; Matsumura A
J Vasc Surg; 2012 Feb; 55(2):506-16. PubMed ID: 22264805
[TBL] [Abstract][Full Text] [Related]
12. Metabolic inhibition of sialyl-Lewis X biosynthesis by 5-thiofucose remodels the cell surface and impairs selectin-mediated cell adhesion.
Zandberg WF; Kumarasamy J; Pinto BM; Vocadlo DJ
J Biol Chem; 2012 Nov; 287(47):40021-30. PubMed ID: 23019334
[TBL] [Abstract][Full Text] [Related]
13. A Atractylodes lancea polysaccharide inhibits metastasis of human osteosarcoma U-2 OS cells by blocking sialyl Lewis X (sLe
Zhong K; Fan S; Yao S; Xu H; Bai S
J Cell Mol Med; 2020 Nov; 24(21):12789-12798. PubMed ID: 32985079
[TBL] [Abstract][Full Text] [Related]
14. Analysis of glycosyltransferase expression in metastatic prostate cancer cells capable of rolling activity on microvascular endothelial (E)-selectin.
Barthel SR; Gavino JD; Wiese GK; Jaynes JM; Siddiqui J; Dimitroff CJ
Glycobiology; 2008 Oct; 18(10):806-17. PubMed ID: 18647941
[TBL] [Abstract][Full Text] [Related]
15. Introducing alpha(1,2)-linked fucose into hepatocarcinoma cells inhibits vasculogenesis and tumor growth.
Mathieu S; Gerolami R; Luis J; Carmona S; Kol O; Crescence L; Garcia S; Borentain P; El-Battari A
Int J Cancer; 2007 Oct; 121(8):1680-9. PubMed ID: 17583578
[TBL] [Abstract][Full Text] [Related]
16. Comparison of sialyl-Lewis a-carrying CD43 and MUC1 mucins secreted from a colon carcinoma cell line for E-selectin binding and inhibition of leukocyte adhesion.
Zhang K; Baeckström D; Brevinge H; Hansson GC
Tumour Biol; 1997; 18(3):175-87. PubMed ID: 9143414
[TBL] [Abstract][Full Text] [Related]
17. Suppression of sialyl Lewis X expression and E-selectin-mediated cell adhesion in cultured human lymphoid cells by transfection of antisense cDNA of an alpha1-->3 fucosyltransferase (Fuc-T VII).
Hiraiwa N; Dohi T; Kawakami-Kimura N; Yumen M; Ohmori K; Maeda M; Kannagi R
J Biol Chem; 1996 Dec; 271(49):31556-61. PubMed ID: 8940172
[TBL] [Abstract][Full Text] [Related]
18. Asparagine synthetase as a causal, predictive biomarker for L-asparaginase activity in ovarian cancer cells.
Lorenzi PL; Reinhold WC; Rudelius M; Gunsior M; Shankavaram U; Bussey KJ; Scherf U; Eichler GS; Martin SE; Chin K; Gray JW; Kohn EC; Horak ID; Von Hoff DD; Raffeld M; Goldsmith PK; Caplen NJ; Weinstein JN
Mol Cancer Ther; 2006 Nov; 5(11):2613-23. PubMed ID: 17088436
[TBL] [Abstract][Full Text] [Related]
19. Selectin ligands on human melanoma cells.
Miller N; Vile RG; Hart IR
Glycoconj J; 1996 Feb; 13(1):33-43. PubMed ID: 8785485
[TBL] [Abstract][Full Text] [Related]
20. IKKβ Regulates VEGF Expression and Is a Potential Therapeutic Target for Ovarian Cancer as an Antiangiogenic Treatment.
Kinose Y; Sawada K; Makino H; Ogura T; Mizuno T; Suzuki N; Fujikawa T; Morii E; Nakamura K; Sawada I; Toda A; Hashimoto K; Isobe A; Mabuchi S; Ohta T; Itai A; Morishige K; Kurachi H; Kimura T
Mol Cancer Ther; 2015 Apr; 14(4):909-19. PubMed ID: 25637316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
